© 2001 The Royal College of Psychiatrists
Intellectual functioning and outcome of patients with severe psychotic illness randomised to intensive case management
Report from the UK700 trial
Department of Psychiatry and Behavioural Sciences, RF & UCMS, London
Department of Medical Statistics and Evaluation, Imperial College School of Medicine, London
Centre for Health Economics, University of York, York
Department of Public Mental Health, London
Department of Psychiatry, St George's Hospital Medical School, London
Harperbury Hospital, Radlett, Hertfordshire
Brixton Community Care Project, Maudsley Hospital, London
Mental Illness Research Unit, University of Manchester, Manchester
Correspondence: Dr A. Hassiotis, Department of Psychiatry and Behavioural Sciences, Royal Free and University College Medical School, Wolfson Building, 48 Riding House Street, London WIN 8AA, UK. Tel: 020 7504 9451; fax: 020 7323 1459; e-mail: a.hassiotis{at}ucl.ac.uk
Declaration of interest Funded by the Department of Health Research and Development Programme.
Background Little research has been carried out on the benefits of intensive case management (ICM) for people with borderline IQ and severe mental illness.
Aims To compare outcome and costs of care of patients with severe psychotic illness with borderline IQ to patients of normal IQ and to assess whether ICM is more beneficial for the former than for the latter.
Method The study utilises data from the UK700 multi-centre randomised controlled trial of case management. The main outcome measure was the number of days spent in hospital for psychiatric reasons. Secondary outcomes were costs of care and clinical outcome.
Results ICM was significantly more beneficial for borderline-IQ patients than those of normal IQ in terms of reductions in days spent in hospital, hospital admissions, total costs and needs and increased satisfaction.
Conclusions ICM appears to be a cost-effective strategy for a subgroup of patients with severe psychosis with cognitive deficits.
This article has been cited by other articles:
 |
|
 |
|
  S. K. Erickson, J. R. Ciccone, S. B. Schwarzkopf, J. S. Lamberti, and M. J. Vitacco Legal Fallacies of Antipsychotic Drugs J Am Acad Psychiatry Law, June 1, 2007; 35(2): 235 - 246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Burns, J. Yiend, and P. Tyrer Authors' reply: The British Journal of Psychiatry, June 1, 2007; 190(6): 538 - 538. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Prakash, T. Andrews, and I. Porter Service innovation: assertive outreach teams for adults with learning disability Psychiatr. Bull., April 1, 2007; 31(4): 138 - 141. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Roberts, J. Cumming, and K. Nelson A Review of Economic Evaluations of Community Mental Health Care Med Care Res Rev, October 1, 2005; 62(5): 503 - 543. [Abstract] [PDF]
|
|
|
|
|
|
P. Tyrer and T. Weaver Desperately seeking solutions: the search for appropriate treatment for comorbid substance misuse and psychosis Psychiatr. Bull., January 1, 2004; 28(1): 1 - 2. [Full Text] [PDF]
|
|
|
|
|
|
T. WEAVER, P. TYRER, J. RITCHIE, and A. RENTON Assessing the value of assertive outreach: Qualitative study of process and outcome generation in the UK700 trial The British Journal of Psychiatry, November 1, 2003; 183(5): 437 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hassiotis, P. Tyrer, and P. Oliver Psychiatric assertive outreach and learning disability services Adv. Psychiatr. Treat., September 1, 2003; 9(5): 368 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. C Oliver, J. Piachaud, D J. Done, A. Regan, S. E Cooray, and P. J Tyrer Difficulties developing evidence-based approaches in learning disabilities Evid. Based Ment. Health, May 1, 2003; 6(2): 37 - 39. [Full Text] [PDF]
|
|
|
|
|
|
B. Thomas Intensive case management decreased hospital resource use in psychotic patients with borderline intelligence quotient Evid. Based Ment. Health, November 1, 2001; 4(4): 110 - 110. [Full Text] [PDF]
|
|